These effects, together with a past report displaying that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the concept of focusing on ACKR3 as a novel strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-related Issues.At that time, Microsoft Advertising and marketing